Preladenant Terminated Phase 3 Trials for Idiopathic Parkinson's Disease / Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01215227An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)